TPG Completes Aptalis Acquisition form Actavis, Renames to Adare
April 06, 2015
TPG has completed its previously announced acquisition of Aptalis Pharmaceutical Technologies from Actavis (NYSE: ACT); the company has been renamed Adare Pharmaceuticals. Adare is a pharmaceutical outsourcing and R&D business operating in the U.S., Canada and Europe. Its specialized capabilities include taste-masking and customized drug release, as well as the ability to support projects from formulation through scale-up and commercial-scale manufacturing. With TPG's backing, the company will seek to expand through new partnerships with other pharmaceutical companies, acquisitions and increased product development.